Parsing Risks and Finetuning Queries: Retina Research from GLP-1 to Curcumin

Parsing Risks and Finetuning Queries: Retina Research from GLP-1 to Curcumin

Join John W Kitchens, MD, and Ehsan Rahimy, MD, to discuss new research in retina, such as GLP-1 receptor agonists and curcumin for inflammation.

Eyes On Eyecare Site Sponsors

Astellas
Recently Published
3 Major Complications in Ocular Oncology Surgery Residents/Fellows Should Know
OCULAR ONCOLOGY
3 Major Complications in Ocular Oncology Surgery Residents/Fellows Should Know

This guide for ophthalmology residents and fellows outlines three major complications of ocular oncology surgery and strategies for reducing their likelihood.

Opening a Successful Ophthalmology Practice: Concentrate on Culture
PRACTICE MANAGEMENT
Opening a Successful Ophthalmology Practice: Concentrate on Culture

Learn how ophthalmologists can build a positive work culture when opening a practice to sustain long-term growth.

Darrell E. White, MDApril 16, 2025
Parsing Risks and Finetuning Queries: Retina Research from GLP-1 to Curcumin
CLINICAL STUDIES & TRIALS
Parsing Risks and Finetuning Queries: Retina Research from GLP-1 to Curcumin

Join John W Kitchens, MD, and Ehsan Rahimy, MD, to discuss new research in retina, such as GLP-1 receptor agonists and curcumin for inflammation.

Clinical
Implantation of a New Full Visual Range IOL
SURGERY
Implantation of a New Full Visual Range IOL

Watch a narrated surgical video of how to implant the TECNIS Odyssey intraocular lens (IOL) and review tips for successfully placing the lens.

3 Major Complications in Cornea Surgery Residents/Fellows Should Know
SURGERY
3 Major Complications in Cornea Surgery Residents/Fellows Should Know

Gain a comprehensive understanding of the top three complications after cornea surgery ophthalmology residents and fellows should know and take the quiz!

Functional and Structural Outcomes in MacTel
CLINICAL GUIDES
Functional and Structural Outcomes in MacTel

Learn how ophthalmologists can identify idiopathic macular telangiectasia type 2 (MacTel) and recent innovations in treatments.

Careers
Opening a Successful Ophthalmology Practice: Concentrate on Culture
PRACTICE MANAGEMENT
Opening a Successful Ophthalmology Practice: Concentrate on Culture

Learn how ophthalmologists can build a positive work culture when opening a practice to sustain long-term growth.

Darrell E. White, MDApril 16, 2025
Sustaining Private Practice in a Consolidating Healthcare Market
PRACTICE MANAGEMENT
Sustaining Private Practice in a Consolidating Healthcare Market

Learn how co-owned MD/OD practices are the perfect answer for a sustaining private surgical practice in a consolidating healthcare market.

Ongoing Challenges for Women in Ophthalmology
CAREERS
Ongoing Challenges for Women in Ophthalmology

Learn about the obstacles women in ophthalmology face, tips from doctors on maneuvering these challenges, and organizations addressing these disparities.

Sponsored Content
Dry Eye Treatment in 2024: Keeping First Things First
DRY EYE

Dry Eye Treatment in 2024: Keeping First Things First

Michael Garanzini, Senior Director of Marketing at Sun Pharma, and Crystal Brimer, OD, FAAO, discuss why focusing on the fundamentals of dry eye and why choosing CEQUA® (cyclosporine ophthalmic solution) 0.09% as your cyclosporine product can make all the difference in treating dry eye.

Our industry partners

ZEISS
National Vision
EssilorLuxottica
Essilor
Johnson & Johnson Vision
ZEISS Professional Education

Find your next eyecare job

Browse Eyecare Jobs (1,000+)Post a Job

Find your next eyecare job